A different study presented at the 2025 ASCO Annual Meeting showed that one specific diet may benefit people with colon ...

Mersana Therapeutics Inc. (NASDAQ:MRSN) is one of the best penny stocks under $1 to buy now. Earlier in June, Mersana ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Some treatments for rheumatoid arthritis could increase cancer risk. One reason is because some cells in our immune system ...

Replimune's RP1 treatment for advanced melanoma faces FDA rejection due to trial design issues, despite promising results ...

Erica Campbell chose a mastectomy. That choice gave her power — and helped her make peace with her biggest regret.

Tempus Announces 10 Abstracts Accepted for Presentation at the 2025 American Society of Clinical Oncology Annual Meeting. Share. CHICAGO--(BUSINESS WIRE) ...

The data were featured during an oral presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 30-June 3, 2025, in Chicago and online.

Intensity Therapeutics, Inc.'s Phase 3 INVINCIBLE-3 Sarcoma Study Selected for Presentation at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting PR Newswire SHELTON, Conn., May ...